- My Forums
- Tiger Rant
- LSU Recruiting
- SEC Rant
- Saints Talk
- Pelicans Talk
- More Sports Board
- Fantasy Sports
- Golf Board
- Soccer Board
- O-T Lounge
- Tech Board
- Home/Garden Board
- Outdoor Board
- Health/Fitness Board
- Movie/TV Board
- Book Board
- Music Board
- Political Talk
- Money Talk
- Fark Board
- Gaming Board
- Travel Board
- Food/Drink Board
- Ticket Exchange
- TD Help Board
Customize My Forums- View All Forums
- Show Left Links
- Topic Sort Options
- Trending Topics
- Recent Topics
- Active Topics
Started By
Message
re: AUPH - Aurinia Pharmaceuticals
Posted on 9/25/18 at 8:52 pm to cuyahoga tiger
Posted on 9/25/18 at 8:52 pm to cuyahoga tiger
0
Posted on 9/25/18 at 8:54 pm to bayoubengals88
I am selling all of my ADMP as soon as it goes green for me and buying more ADMP. I want at least 10,000 shares of this.
Posted on 9/25/18 at 9:53 pm to bayoubengals88
I may jump in this tomorrow...
Posted on 9/25/18 at 10:34 pm to LSUmajek
hefty 200,000 after hours volume today with 30,000 shares bought at 6.05 (someone bought 180k at once).
For reference, daily volume has been 100-200k for a few weeks so that was a giant afternoon.
The morning will be a war to stay above $6
Be patient. Get some shares under $6, but revisit in a month and see if it goes back to mid 5's.
EDIT: Catalysts today included
1) finalization of enrollment for phase 3 (10% extra participants and ahead of schedule).
2) Cantor Fitzgerald $18 price target rolled out today.
For reference, daily volume has been 100-200k for a few weeks so that was a giant afternoon.
The morning will be a war to stay above $6
Be patient. Get some shares under $6, but revisit in a month and see if it goes back to mid 5's.
EDIT: Catalysts today included
1) finalization of enrollment for phase 3 (10% extra participants and ahead of schedule).
2) Cantor Fitzgerald $18 price target rolled out today.
This post was edited on 9/25/18 at 10:39 pm
Posted on 11/8/18 at 5:26 pm to bayoubengals88
Any updates from the earnings call?
Posted on 11/8/18 at 5:57 pm to Caymus
I saw ole baw is retiring
This post was edited on 11/8/18 at 5:58 pm
Posted on 11/25/18 at 7:07 am to Turftoe
Anyone still got skin in this game?
Posted on 11/26/18 at 11:04 am to LSURoss
I do. I'm down $6 right now overall on it. basically just waiting for a moonshot or stop loss to kick in
Posted on 11/26/18 at 7:27 pm to Turftoe
quote:not sure what to think about this.
I saw ole baw is retiring
He retired before his last drug sold as well
...the one that AUPH is supposed to add voclorsporin to in order for it to work better. He'll be around for a while. Maybe he thinks he'll sell it prior to retiring. Maybe he'll remain on the board. Maybe he thinks the company can go at it alone, or maybe he doesn't have the desire or longevity to develop the company after phase 3.
All that said, AUPH is doing ok considering all the other pharmas I follow. AKAO, ADMP, SCYX, SAGE, PULM, ABBV
Data readings come in January for VOS, the competitor to Restasis. VOS is supposed to be better in every way. More potent, quicker results, fewer side effects.
Restasis is worth north of a billion in sales per year. Do the math. The future is bright. I'd suspect they sell this aspect of the company and stick to Renal diseases.
This post was edited on 11/26/18 at 7:29 pm
Posted on 11/28/18 at 10:32 am to bayoubengals88
Did some research last night about phase 3 to FDA approvals and the timeline can be anywhere from immediate to years. Not sure how I feel about that but I do believe if they have positive results after Phase 3, the FDA would be pressured for a timely approval.
That being said, I do think they are going to have positive results post phase 3. The stock has hovered around the mid to low $5's the last month after the jump in Sept-Oct. Will surely consider expanding my position if the price stays here. Anyone else looking to expand position?
That being said, I do think they are going to have positive results post phase 3. The stock has hovered around the mid to low $5's the last month after the jump in Sept-Oct. Will surely consider expanding my position if the price stays here. Anyone else looking to expand position?
quote:Do you think they will immediately sell? What makes me nervous is if they sell, are they selling rights (royalties) or selling the drug in its entirety which could fetch massive figures and how would that gain be distributed via shareholders vs reinvesting internally on R&D.
suspect they sell this aspect of the company and stick to Renal diseases.
Posted on 11/29/18 at 1:08 pm to Rendevoustavern
Up 9.5% today. Wild ride indeed.
Posted on 11/29/18 at 1:19 pm to ynlvr
quote:
Up 9.5% today.
Posted on 11/29/18 at 1:23 pm to bayoubengals88
Just means it finally got back to $6. But then you are as familiar with AUPH's bad habits as anybody. I am still expecting on the big payoff as early as next year.
Posted on 11/29/18 at 1:26 pm to Rendevoustavern
quote:
Do you think they will immediately sell? What makes me nervous is if they sell, are they selling rights (royalties) or selling the drug in its entirety which could fetch massive figures and how would that gain be distributed via shareholders vs reinvesting internally on R&D.
All I know is that Glickman has mentioned sticking to renal diseases. Most suspect they will sell VOS. I don't know what that will look like for share holders, but receiving large cash payments is probably a good thing for a company that is still in development.
Posted on 12/3/18 at 9:40 am to ynlvr
There was a lot of talk about Aurinia's statement from last Friday.
Essentially, the company secured a deal to have access to 30 million dollars when and if it needs it.
Many investors feared news that the possibility of a small dilution would ruin any momentum gained from last week as AUPH finished above $6 on Friday.
However, this has not been the case as the market has reacted well with the stock currently trading at $6.15 on healthy volume.
There is speculation that Aurinia has secured the 30 million to fund a phase III for VOS against Allergen's Restasis (for dry eye syndrome).
Essentially, the company secured a deal to have access to 30 million dollars when and if it needs it.
Many investors feared news that the possibility of a small dilution would ruin any momentum gained from last week as AUPH finished above $6 on Friday.
However, this has not been the case as the market has reacted well with the stock currently trading at $6.15 on healthy volume.
There is speculation that Aurinia has secured the 30 million to fund a phase III for VOS against Allergen's Restasis (for dry eye syndrome).
This post was edited on 12/3/18 at 9:48 am
Posted on 12/3/18 at 10:57 am to bayoubengals88
Saw a dip in post close Friday, down to 5.97 but rebounded on the open this AM.
My anticipation is building especially after this announcement:
My anticipation is building especially after this announcement:
quote:
BY Reuters — 5:21 PM ET 11/30/2018 Nov 30 (Reuters)* AURINIA PHARMACEUTICALS ( AUPH ) - INTENDS TO USE PROCEEDS TO FUND OPERATIONS, INCLUDING CLINICAL DEVELOPMENT AND COMMERCIAL PRODUCTION OF VOCLOSPORIN
Posted on 12/3/18 at 12:29 pm to Rendevoustavern
Posted on 12/3/18 at 12:45 pm to LSURoss
Up 41% ytd
Posted on 12/3/18 at 12:58 pm to bayoubengals88
I’m still holding a nice position as well patiently waiting.
Posted on 12/28/18 at 11:10 am to cuyahoga tiger
52 week high got hit today.
my robinhood app blew up whenever I last checked. i've gone from down in the stock to up over a dollar a share.
my robinhood app blew up whenever I last checked. i've gone from down in the stock to up over a dollar a share.
Page 12 of 164
Popular
Back to top
Follow TigerDroppings for LSU Football News